From: Structural brain abnormalities in Pallister-Killian syndrome: a neuroimaging study of 31 children
Code | Sex | Genetics | n° of MRIs | Age at 1st MRI (years) | Time between MRIs (years) | Age at last clinical evaluation (years) | Seizures | Severe Vision Impairment | Developmental delay | SDSC score |
---|---|---|---|---|---|---|---|---|---|---|
Case 1 | f | n/a | 1 | 0.1 | Â | 1.2 | n | y | severe | n/a |
Case 2 | f | 47, XX, i(12)(p10) [1]/46, XX,[99] (karyotype on blood) | 1 | 0.1 | Â | 3 | y | n | moderate | 50 |
Case 3 | m | 47,XY, i(12)(p10) [19]/46,XY [16] (karyotype on fibroblasts from hyperchromic skin biopsy) arr[GRCh37] 12p13.33p11.1 (191619_34853011)x2-4 (SNP array on hyperchromic skin biopsy) | 2 | 0.3 | 2.6 | 3 | y | n | moderate | 54 |
Case 4 | f | arr12p13.33p11.1 (Array-CGH on unknown sample) | 1 | 0.3 | Â | 7.2 | y | n/a | n/a | n/a |
Case 5 | f | arr[GRCh37] 12p13.33p11.1 (191619_34826574)x2-4 (Array-CGH on unknown sample) | 2 | 0.4 | 0.4 | 2.4 | n | n | severe | 70 |
Case 6 | f | arr[hg19]12p13.33p11.1 (0-43257397 × 3, 34,294,005 × 2) (Array-CGH on unknown sample) | 1 | 0.4 |  | 1.4 | n | y | severe | n/a |
Case 7 | m | 47, XY, +i(12)(p10) [20]/46, XY [4] (Karyotype on fibroblasts) | 1 | 0.8 | Â | 2.5 | y | y | severe | 90 |
Case 8 | f | arr12pterp11.1 (163,593 − 34,398,316)x2-4 (Array-CGH on blood) | 1 | 0.8 |  | 10.8 | y | n | mild | 45 |
Case 9 | f | arr [hg19] 12p13.33p11.1 (163, 679 − 34,760,977) x2 3 (Array-CGH on blood) | 2 | 0.9 | 0.4 | 1.5 | n | n | severe | 64 |
Case 10 | f | ish12(D1221 × 3,wep12 × 3,pcp12p11.2p13 × 4) [21]/12(D12Z1 × 2,wep12 × 2, pep12p11.2p13 × 2) [22] (FISH on fibroblasts) | 2 | 0.9 | 3.3 | 3.7 | y | n/a | moderate | n/a |
Case 11 | m | 2 | 1 | 1.2 | 6.4 | y | y | severe | 99 | |
Case 12 | f | arr12p13.33p11.1 (Array-CGH on buccal epithelial cells) | 1 | 1 | Â | 6.3 | n | y | severe | 62 |
Case 13 | m | n/a | 1 | 1.2 | Â | 7.5 | y | y | n/a | n/a |
Case 14 | m | Mos 47, XY arr[hg19] 12p13.33p11.1(148,375 − 34,760,977)x3 (karyotype on blood) | 1 | 1.4 |  | 7.4 | y | n | severe | n/a |
Case 15 | m | 47,XY + i(12p) [22],46,XY [5].ishi(12p)(cp12) (karyotype on fibroblasts) | 1 | 1.5 |  | 1.4 | y | y | severe | n/a |
Case 16 | m | n/a | 1 | 1.6 | Â | 2.7 | y | y | severe | n/a |
Case 17 | f | 47,XX,+i(12)(p10) [6]/46,XX [4] (karyotype on blood); arr[GRCh37)12p13.33p11.1(194249_34398316)x3-4 (Array-CGH on blood) | 1 | 2 | Â | 4.3 | n | n | mild | n/a |
Case 18 | f | 47,XX, +i(12p)(p10) [24]/46,XX [3] (karyotype on fibroblasts) | 1 | 2.4 | Â | 2.4 | n | n | mild | 62 |
Case 19 | m | 47, XY, i(12)(p10)/46, XY (karyotype on fibroblasts) | 1 | 2.7 | Â | 16.4 | y | y | severe | n/a |
Case 20 | m | arr12p13.33p11.2 (Array-CGH on unknown sample) | 1 | 3 | Â | 9 | y | n/a | severe | n/a |
Case 21 | f | Ish 12p13(TELx2) [25]/12p13 (TEL x 3) [26] 12p13(TELx4 [24] (FISH on buccal epithelial cells) | 1 | 3.7 | Â | 4.5 | y | n | mild | n/a |
Case 22 | f | 47, XX, i(12)(p10) [2]/46, XX [98] (karyotype on amniocentesis) | 1 | 4.1 | Â | 11.8 | n | y | severe | 51 |
Case 23 | f | arr [hg19] 12p13.33p11.1 (163, 618 − 34,756,180) x2-3 (Array-CGH on blood) | 1 | 4.5 |  | 10.2 | y | y | moderate | 100 |
Case 24 | f | 46, XX [21],47XX + i(12p) [22] (karyotype on fibroblasts) | 1 | 4.9 | 12.7 | 17.6 | y | y | severe | 68 |
Case 25 | f | Ish 12p13 (TELx4) [27]/(TELX3) [28]/(TELX2) [29] (FISH on buccal epithelial cells) | 1 | 4.9 | Â | 5 | y | y | severe | n/a |
Case 26 | m | n/a | 1 | 7 | Â | 18.2 | y | y | severe | n/a |
Case 27 | m | 12p13.33p11.1 (Array-CGH on unknown sample) | 1 | 9.1 | Â | 11.7 | y | n | mild | n/a |
Case 28 | m | 47,XY, i(12)(p10) (karyotype on blood) | 1 | 11.4 | Â | 17.4 | y | y | severe | 62 |
Case 29 | f | 47, XX, i(12p) (karyotype on blood) | 1 | 11.6 | Â | 11.6 | y | n | moderate | 69 |
Case 30 | m | 47, XY, i(12)(p10)/46, XY (karyotype on buccal epithelial cells) | 1 | 13.1 | Â | 14.4 | n | n | severe | 62 |
Case 31 | m | 47, XX, i(12p) (karyotype on fibroblasts) | 1 | 17.5 | Â | 17.6 | y | n/a | severe | n/a |